NASDAQ
Genex Pharmaceutical, Inc. (GENX) has a free cash flow growth of -97.93% as of Friday, May 29, 2026. This represents a 1142.53% decrease compared to its 12-month average of -7.88%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.